Concepedia

Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients

Michalis Liontos, Evangelos Terpos, Elena Kunadis, Flora Zagouri, Αlexandros Briasoulis, Oraianthi Fiste, Christos Markellos, Αngeliki Andrikopoulou, Sentiljana Gumeni, Maria Kaparelou,

Prostate Cancer and Prostatic Diseases · 2021 · 12 citations · 5 references

DOIFull text

Open access

Concepts

References

5

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose

Evangelos Terpos, Ioannis P. Trougakos, Maria Gavriatopoulou et al. · Blood · 2021 · 148 citations · Full text

, , +16

Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse

Yang Pu, Meng Xu, Yong Liang et al. · Science Translational Medicine · 2016 · 105 citations

, , +13

Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression

Camila Rosat Consiglio, Olga Udartseva, Kimberly D. Ramsey et al. · Cancer Immunology Research · 2020 · 50 citations · Full text

, , +17

Commentary: SARS-CoV-2 vaccines and cancer patients

Chiara Corti, Giuseppe Curigliano · Annals of Oncology · 2021 · 50 citations · Full text

, , +13

Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis

Adam Booth, Angus B. Reed, Sonia Ponzo et al. · medRxiv · 2020 · 41 citations · Full text

, , +13